Ethicon, Inc. is a subsidiary of Johnson & Johnson. It was incorporated as a separate company under the Johnson & Johnson umbrella in 1949 to expand and diversify the Johnson & Johnson product line. Ethicon has manufactured surgical sutures and wound closure devices since 1887. After World War II, Ethicon's market share in surgical sutures rose from 15% to 70% worldwide. In the United States, the market share is approximately 80%.

Histogenics is a regenerative medicine company focused on developing and commercializing products in the musculoskeletal segment of the marketplace. Our regenerative medicine platform combines expertise in cell processing, scaffolding, tissue engineering, bioadhesives and growth factors to provide solutions that can be utilized individually or in concert to treat musculoskeletal-related conditions. Our first investigational product candidate, NeoCart®, leverages our platform to provide an innovative treatment in the orthopedic space, specifically cartilage damage in the knee.

Isolagen Technologies, Inc. researches and develops cellular technology. specializes in the development and commercialization of autologous cellular system. The company is headquartered in Houston, TX.

Wright Medical Technology, Inc., a subsidiary of Stryker Corp., is a company headquartered in Arlington, TN. The firm manufactures orthopedic, prosthetic, and surgical appliances and supplies.

Jiangsu Youchuang Biomedical Technology Co., Ltd., established on 1992-07-06, The business scope includes three categories6864Medical hygiene materials and dressings,6846Implant materials and artificial organ development,to develop,manufacture,Sales,one type6816burn(plastic surgery)R&D of Surgical Instruments,manufacture,Sales,Class I medical device,Fitness Equipment,Instrumentation,Daily necessities,Medical Hygienic Materials,Chemical product sales.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Tissue Regenix was established in May 2006, to commercialize innovative technologies in regenerative medicine. The underpinning science was developed over the last decade in the world-leading Institute for Medical and Biological Engineering at the University of Leeds by Professors John Fisher and Eileen Ingham. The research has received in excess of £4 million grant funding to date from UK research councils (EPSRC, BBSRC) and the Children's Heart Surgery Fund.\nThe business has exclusive rights over several platform technologies in regenerative tissue engineering. Tissue Regenix is led by a team of highly experienced medical device industry veterans with a strong track record of translating early developmental work into products that are currently benefitting patients worldwide in a range of clinical settings from heart valves to orthopedic implants.\nTissue Regenix is focused on delivering its lead product, the dCELL Vascular Patch, into the clinic. Follow on products include the dCELL Meniscus, as well as an extensive pipeline of other product offerings in the vascular, cardiac and orthopedic areas.\nThe company is committed to pursuing the highest standards of product safety and quality and has retained world-class independent advisors to ensure the dCELL range meets or exceeds these.

LifeCell develops and markets tissue repair products for use in reconstructive, urogynecologic, and orthopedic surgical procedures. Its products include reconstructive and regenerative tissue matrixes, such as Strattice and AlloDerm for plastic, reconstructive, general surgical, burn, and periodontal procedures; Cymetra for injection; Repliform for urogynecologic surgical procedures; GraftJacket for orthopedic surgical procedures; and AlloCraft DBM for bone grafting procedures. Its products are used in applications, such as abdominal wall reconstruction, hernia repair, breast reconstruction, breast plastic surgery, grafting, and ENT/head and neck plastic reconstruction. It offers its products to patients and healthcare professionals through distributors in the United States and internationally. The company was founded in 1986 and is headquartered in Branchburg, New Jersey. As of May 27, 2008, LifeCell Corporation operates as a subsidiary of Kinetic Concepts Inc.

Shanghai Zhuoruan Medical Technology Co., Ltd., established on 2015-07-20, Business scope includes medical technology,Material Technology,Technology development in the field of biotechnology specialization,technical consulting,Technical Services,technology transfer(GMOs,Except human stem cell genetic diagnosis),Class I medical device,chemical reagent(except medical,Diagnostic reagents),Chemical raw materials and products(Removal of hazardous chemicals,Monitor Chemicals,firecrackers,civilian explosives,precursor chemicals)promotion of.[Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Zuoruan Medical Technology (Suzhou) Co., Ltd., established on 2016-08-24, Business scope includes licensed projects:Production of Class III Medical Devices;Class III medical device business;Production of Class II Medical Devices;medical service(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results) General project:Engineering and Technology Research and Experimental Development;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Production of Class I Medical Devices;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Chemical product sales(No licensed chemical products);Specialty Chemicals Sales(Free of Hazardous Chemicals);Retailing of Edible Agricultural Products(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Beijing Dikang Pharmaceutical Investment Management Co., Ltd., established on 2010-12-23, Business scope includes investment management;technology development,transfer,consult;Enterprise Management Services;Medical research and experimental development;Sales of medical devices Class I,Class II,hygiene products,cosmetic,daily necessities;Agent import and export,Import and export;Production of Class I medical devices;Sales of Class III Medical Devices;Production of the second class,Class III medical devices.(Enterprises independently choose operating projects according to law,Carry out business activities;Production of the second class,Class III medical devices,Sales of Class III medical devices and items subject to approval according to law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the city's industrial policies.)

The 301 Hospital (Chinese: 三〇一医院) or People's Liberation Army General Hospital (Chinese: 中国人民解放军总医院), which constitutes simultaneously the PLA Postgraduate Medical School (Chinese: 中国人民解放军医学院), located in Beijing, China, is a military hospital directly subsidiary to Logistic Support Department of the Central Military Commission and the largest general hospital under the auspices of the People's Liberation Army. Its mission includes assuring the health of PLA and China's leaders.

Guangzhou Juming Biotechnology Co., Ltd., established on 2016-02-01, Business scope includes new material technology transfer services;New material technology development service;Medical Research and Experimental Development;Biomedical Technology Research;Gene drug development;Health Sciences Program Research,to develop;

Hangzhou Huamai Medical Technology Co., Ltd., established on 2016-12-21, Business scope includes general items:Production of Class I Medical Devices;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Manufacturing of bio-based materials;Sales of bio-based materials(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).licensed items:Production of Class II Medical Devices;Production of Class III Medical Devices;Class III medical device business(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results).

Beijing Ruijian High-tech Biological Technology Co. Ltd., a subsidiary of PW Medtech Group Ltd., is a company headquartered in China. The firm engages in research and development of medical biomaterials. It was acquired by Medfusion Investment Ltd. on April 29, 2022 for $64.63 million.

Founded in 1969, Mentor Worldwide LLC is a leading supplier of medical products for the global aesthetic medicine market. The Company develops, manufactures, and markets innovative, science-based products for aesthetics markets around the world. Headquartered in Irvine, California, Mentor has manufacturing and research operations in the United States, and the Netherlands.

Guangzhou Xincheng Biotechnology Co., Ltd., established on 2013-03-04, Business scope includes biotechnology development services;Biotechnology Consulting,communication service;Biotechnology Transfer Services;Import and export(Excluding franchised products);Technology Import and Export;Instrument wholesale;Operation of non-licensed medical devices(i.e. no application required<Medical device operating enterprise license>ready-to-operate medical device",Including Class I medical devices and national regulations do not require application<Medical device operating enterprise license>Ready-to-operate Class II Medical Devices);Chemical Reagent and Auxiliary Manufacturing(Monitor Chemicals,Excluding hazardous chemicals);Wholesale of chemical products(Excluding hazardous chemicals);Office Equipment Wholesale;Manufacture of plastic products for medical and sanitary use;

Shanghai Baiyiyuan Biological Engineering Co., Ltd., established on 2011-11-18, Business scope includes biological,Technology development in the field of medical science and technology,technical consulting,technology transfer,Technical Services,Research and development of biological products,Medical device production(see license),Engaged in the production of wound healing biofilms,Medical device management,Cosmetic sales. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Peking University Third Hospital is a private company headquartered in Beijing, China, that operates as a clinic.